The discussions highlighted common challenges in evidence generation, financing and reimbursement, social, regulatory, and infrastructure for better #PrecisionMedicine access in Asia, as well as opportunities for regional collaboration and shared learning.
3 models: info sharing | collective bargaining | central purchasing
⚙️ Success = political will + harmonisation + financing
🚀 Next steps: pilot small, commit politically, learn together
🌏 ASEAN is ready. Now it’s time to act.
What is this report about? 📑How can countries make antibiotics more affordable & accessible? Our study, HITAP, WHO & Global Antibiotic Research & Development Partnership (GARDP) reviewed 33 global mechanisms.
💡 What works
✅ better pricing
✅ reliable supply
✅ quality assurance
✅ regional solidarity
Shiela from HITAP presented on “Cost-effectiveness of prevention strategies to mitigate antimicrobial resistance (AMR)” at the ESCMID Science-Policy Forum: Evidence for Policy – Modelling and Economics during ESCMID Global 2026 in Munich, Germany (17 April 2026).
📃Shared experiences from Thailand & Southeast Asia on building HTA capacity to support better health decisions. 🎉